DK1866650T3 - Neurodegenerative markører for depression - Google Patents

Neurodegenerative markører for depression

Info

Publication number
DK1866650T3
DK1866650T3 DK06723873.3T DK06723873T DK1866650T3 DK 1866650 T3 DK1866650 T3 DK 1866650T3 DK 06723873 T DK06723873 T DK 06723873T DK 1866650 T3 DK1866650 T3 DK 1866650T3
Authority
DK
Denmark
Prior art keywords
depression
markers
disease
values
alzheimer
Prior art date
Application number
DK06723873.3T
Other languages
English (en)
Inventor
Manfred Schawaller
Markus J Schwarz
Norbert Mueller
Aye Mu Myint
Robert Verkerk
Original Assignee
Univ Maastricht
Univ Antwerp
Klinik Und Poliklinik Fuer Psy
Verstappen Leopold
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Maastricht, Univ Antwerp, Klinik Und Poliklinik Fuer Psy, Verstappen Leopold filed Critical Univ Maastricht
Application granted granted Critical
Publication of DK1866650T3 publication Critical patent/DK1866650T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9406—Neurotransmitters
    • G01N33/942—Serotonin, i.e. 5-hydroxy-tryptamine
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2821—Alzheimer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/145555—Hetero-N

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Eye Examination Apparatus (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Mushroom Cultivation (AREA)
  • Input From Keyboards Or The Like (AREA)
DK06723873.3T 2005-04-06 2006-03-30 Neurodegenerative markører for depression DK1866650T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05007558 2005-04-06
PCT/EP2006/002907 WO2006105907A1 (en) 2005-04-06 2006-03-30 Neurodegenerative markers for psychiatric conditions

Publications (1)

Publication Number Publication Date
DK1866650T3 true DK1866650T3 (da) 2010-09-06

Family

ID=36293430

Family Applications (2)

Application Number Title Priority Date Filing Date
DK09013088.1T DK2146209T3 (da) 2005-04-06 2006-03-30 Neurodegenerative markører for Alzheimer's sygdom
DK06723873.3T DK1866650T3 (da) 2005-04-06 2006-03-30 Neurodegenerative markører for depression

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK09013088.1T DK2146209T3 (da) 2005-04-06 2006-03-30 Neurodegenerative markører for Alzheimer's sygdom

Country Status (13)

Country Link
US (2) US20080131921A1 (da)
EP (2) EP2146209B1 (da)
JP (1) JP4958893B2 (da)
AT (2) ATE468537T1 (da)
CY (1) CY1110116T1 (da)
DE (1) DE602006014379D1 (da)
DK (2) DK2146209T3 (da)
ES (2) ES2377704T3 (da)
NO (2) NO20075671L (da)
PL (2) PL2146209T3 (da)
PT (2) PT1866650E (da)
SI (1) SI1866650T1 (da)
WO (1) WO2006105907A1 (da)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008016101A1 (en) * 2006-08-04 2008-02-07 Ajinomoto Co., Inc. Method for evaluation of stress, stress evaluation apparatus, stress evaluation method, stress evaluation system, stress evaluation program, and recording medium
AT9843U1 (de) * 2007-03-27 2008-04-15 Kepplinger Berthold Dr Messung von biologischen markern
DK2240781T3 (da) 2008-01-18 2018-03-26 Harvard College Fremgangsmåder til detektering af sygdoms- eller tilstandssignaturer i kropsfluider
WO2009096502A1 (ja) * 2008-01-31 2009-08-06 Japan As Represented By President Of National Center Of Neurology And Psychiatry うつ病およびうつ状態のマーカーおよびそれを用いた検出・診断
WO2009100243A2 (en) * 2008-02-05 2009-08-13 University Of Miami Elavl4 as a predictor of depression in alzheimer's disease and parkinson's disease patients
EP2466312B1 (en) 2009-08-12 2019-10-16 Human Metabolome Technologies, Inc. Phosphoethanolamine as biomarker of depression
AU2011280997A1 (en) 2010-07-23 2013-02-28 President And Fellows Of Harvard College Methods of detecting autoimmune or immune-related diseases or conditions
CA2806304A1 (en) 2010-07-23 2012-01-26 President And Fellows Of Harvard College Methods of detecting prenatal or pregnancy-related diseases or conditions
WO2012012693A2 (en) 2010-07-23 2012-01-26 President And Fellows Of Harvard College Methods for detecting signatures of disease or conditions in bodily fluids
EP2596134B1 (en) 2010-07-23 2020-04-08 President and Fellows of Harvard College Methods of detecting diseases or conditions using phagocytic cells
WO2013069645A1 (ja) 2011-11-10 2013-05-16 ヒューマン・メタボローム・テクノロジーズ株式会社 エタノールアミンリン酸の測定方法
WO2013188846A1 (en) 2012-06-15 2013-12-19 Harry Stylli Methods of detecting diseases or conditions
EP2861788B1 (en) 2012-06-15 2018-10-10 Progenity, Inc. Methods of detecting diseases or conditions using circulating diseased cells
WO2014068144A1 (en) 2012-11-05 2014-05-08 Ospedale San Raffaele S.R.L. Biomarkers of multiple myeloma development and progression
EP2965077B1 (en) 2013-03-09 2022-07-13 Harry Stylli Methods of detecting cancer
US11585814B2 (en) 2013-03-09 2023-02-21 Immunis.Ai, Inc. Methods of detecting prostate cancer
EP2799878A1 (en) * 2013-05-03 2014-11-05 SALION GmbH In vitro method for the early detection of a potential inflammation, in particular associated with rejection of a transplant using kynurenine as a marker.
US20160003857A1 (en) * 2014-07-02 2016-01-07 Cecil Bennett Methods and systems for detecting polypharmacy
MA40636A (fr) 2014-09-11 2015-09-11 Colleen Kelly Procédés pour détecter le cancer de la prostate
US11806385B2 (en) 2016-04-22 2023-11-07 Board Of Regents Of The University Of Nebraska Biomarkers for monitoring immune transformation
EP3413050A1 (en) * 2017-06-08 2018-12-12 SALION GmbH In vitro method for the determination of neurodegenerative diseases
EP3688186A4 (en) * 2017-09-27 2021-10-13 University of North Carolina Wilmington SCREENING TOOL FOR HUMAN-DERIVED PATHOGENIC AGENTS AND HUMAN WASTEWATER
WO2019181830A1 (ja) 2018-03-19 2019-09-26 富士フイルム和光純薬株式会社 精神疾患の判定方法
JP6678982B2 (ja) * 2018-03-22 2020-04-15 株式会社 日本医療機器技研 生体吸収性ステント
KR102159344B1 (ko) * 2019-08-05 2020-09-23 한국과학기술연구원 행위 중독의 진단용 조성물, 키트 및 이를 이용한 행위 중독의 진단을 위한 키누레닌의 검출 방법
EP4067903A4 (en) * 2019-11-26 2024-03-06 Kyocera Corporation STRESS MEASUREMENT SYSTEM AND STRESS MEASUREMENT METHOD
JP2023549028A (ja) * 2020-10-06 2023-11-22 学校法人沖縄科学技術大学院大学学園 アルツハイマー病（ａｄ）の診断のための指標を得るための方法
JPWO2024253194A1 (da) * 2023-06-08 2024-12-12
CN118566488B (zh) * 2024-04-10 2026-02-27 合肥歆智医疗器械有限公司 抑郁症检测用试剂组合、制造方法、检测系统及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6194217B1 (en) * 1980-01-14 2001-02-27 Esa, Inc. Method of diagnosing or categorizing disorders from biochemical profiles
JP2000131318A (ja) * 1998-10-22 2000-05-12 Nikken Foods Co Ltd 快・不快ストレス状態解析方法
EP1050758A1 (en) * 1999-05-03 2000-11-08 Evotec BioSystems AG Methods of diagnosing or treating neuropsychiatric diseases on basis of increased cerebrospinal fluid levels of neurotrophin 3
FR2827045B1 (fr) * 2001-07-05 2007-08-10 Univ Pasteur Methodes et compositions pour la selection et le developpement de nouveaux agents pharmacologiques ou de nouveaux medicaments
JP2004198325A (ja) * 2002-12-19 2004-07-15 Oriental Yeast Co Ltd ストレスの測定方法

Also Published As

Publication number Publication date
ES2377704T3 (es) 2012-03-30
PL2146209T3 (pl) 2012-05-31
EP1866650A1 (en) 2007-12-19
US20080131921A1 (en) 2008-06-05
NO20075671L (no) 2007-11-06
PL1866650T3 (pl) 2011-04-29
ATE534038T1 (de) 2011-12-15
JP4958893B2 (ja) 2012-06-20
PT1866650E (pt) 2010-06-01
EP2146209B1 (en) 2011-11-16
WO2006105907A1 (en) 2006-10-12
ATE468537T1 (de) 2010-06-15
CY1110116T1 (el) 2015-01-14
PT2146209E (pt) 2011-12-30
ES2346467T3 (es) 2010-10-15
EP1866650B1 (en) 2010-05-19
HK1137219A1 (en) 2010-07-23
US20120196300A1 (en) 2012-08-02
DE602006014379D1 (de) 2010-07-01
SI1866650T1 (sl) 2010-12-31
NO20120452L (no) 2007-11-06
JP2008537111A (ja) 2008-09-11
EP2146209A1 (en) 2010-01-20
DK2146209T3 (da) 2012-02-13

Similar Documents

Publication Publication Date Title
DK1866650T3 (da) Neurodegenerative markører for depression
WO2006134390A3 (en) Method for diagnosing neurodegenerative disease
WO2005047484A3 (en) Biomarkers for alzheimer's disease
DK1945622T3 (da) Isotopisk-mærkede benzofuranforbindelser som billeddannelsesmidler til amyloidogene proteiner
EP1946070A4 (en) HYDROGEN SENSOR
EP1956962A4 (en) METHOD FOR DETERMINING THE FORM OF A BENDABLE INSTRUMENT
EP1700096A4 (en) PROOF OF PROTEINS AND PRIONS WITH CHANGED CONFORMATION
WO2007106762A3 (en) Alzheimer's disease biomarkers and methods of use
MX2007016136A (es) Metodo para diagnosticar la enfermedad de alzheimer.
ZA200810528B (en) Procedure and methods for detecting Alzheimer's disease
FR2874675B1 (fr) Frein pour roue avec capteur d'usure
WO2010043393A8 (en) Use of biglycan in the assessment of heart failure
WO2005124356A3 (en) Use of protein cbp2 as a marker for colorectal cancer
DE602007004570D1 (de) Verwendung von Nogo-C bei der Beurteilung von Herzversagen
EP1856526A4 (en) THIOREDOXIN-INTERACTING PROTEIN (TXNIP) AS REGULATOR OF VASCULAR FUNCTION
EP1877154A4 (en) METHOD FOR DETECTING, IDENTIFYING AND QUANTIFYING CONTAMINATION
DK1639139T3 (da) Fremgangsmåder til påvisning af Alzheimers sygdom
BRPI0512655A (pt) bioexame de rna
WO2005116659A3 (en) Compositions and methods relating to alzheimer’s disease
ATE408827T1 (de) Quantifizierung von stressbelastung
FR2852096B1 (fr) Instrument indicateur de direction permettant d'indiquer l'heure et la direction de la mecque.
ATE442084T1 (de) Messung des energieverbrauchs
EP1907838A4 (en) FRAGMENT OF THE NEUROSCRETOR PROTEIN VGF AS BIOMARKER FOR MORBUS ALZHEIMER
GB0622194D0 (en) Method for diagnosing or detecting alzheimer's disease
UA11938S (uk) Кашкет чоловічий формений